| Advancements in circulating tumor cell research: bridging biology and clinical applications P Salu, KM Reindl Cancers 16 (6), 1213, 2024 | 8 | 2024 |
| Advancements in Preclinical Models of Pancreatic Cancer P Salu, KM Reindl Pancreas 53 (2), e205-e220, 2024 | 4 | 2024 |
| Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer PM Giri, A Kumar, P Salu, V Sathish, K Reindl, S Mallik, B Layek Biomedicine & Pharmacotherapy 175, 116743, 2024 | 2 | 2024 |
| AGR2 knockdown induces ER stress and mitochondria fission to facilitate pancreatic cancer cell death P Salu, D Tuvin, KM Reindl Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1872 (1), 119854, 2025 | | 2025 |
| Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer PM Giri, A Banerjee, A Ghosal, P Salu, K Reindl, B Layek International Journal of Pharmaceutics 666, 124753, 2024 | | 2024 |
| Abstract LB192: AGR2 knockdown reduces cell proliferation and increases endoplasmic reticulum proteotoxic stress in pancreatic cancer P Salu, K Reindl Cancer Research 84 (7_Supplement), LB192-LB192, 2024 | | 2024 |
Katie ReindlProfessor of Biological Sciences, North Dakota State University在 ndsu.edu 的电子邮件经过验证
Katie ReindlProfessor of Biological Sciences, North Dakota State University在 ndsu.edu 的电子邮件经过验证